Ascendis’ TransCon Positioned To Take On BioMarin’s Voxzogo

 
• By Jessica Merrill

The Danish company released pivotal data for TransCon CNP in children with achondroplasia that appears competitive with BioMarin’s big growth driver.

Ascendis announced positive Phase III data that hit the mark with investors • Source: Shutterstock

More from Rare Diseases

More from Scrip